Common Stock, Shares, Outstanding of Vivos Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Vivos Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Vivos Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 8,266,877, a 73% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Vivos Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 8,266,877 +3,501,577 +73% 30 Sep 2025 10-Q 19 Nov 2025 2025 Q3
Q2 2025 7,324,807 +3,923,319 +115% 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 5,889,520 +3,158,250 +116% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 5,889,520 +4,055,643 +221% 31 Dec 2024 10-Q 19 Nov 2025 2025 Q3
Q3 2024 4,765,300 +3,568,042 +298% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 3,401,488 -26,527,298 -89% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 2,731,270 -27,197,516 -91% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 1,833,877 +913,285 +99% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 1,197,258 -21,814,861 -95% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 29,928,786 +6,916,667 +30% 30 Jun 2023 10-Q 16 Aug 2023 2023 Q2
Q1 2023 29,928,786 +6,916,667 +30% 31 Mar 2023 10-Q 08 Jun 2023 2023 Q1
Q4 2022 920,592 -22,091,527 -96% 31 Dec 2022 10-K/A 30 Jul 2024 2023 FY
Q3 2022 23,012,119 0 0% 30 Sep 2022 10-Q 20 Dec 2022 2022 Q3
Q2 2022 23,012,119 +200,000 +0.88% 30 Jun 2022 10-Q 20 Dec 2022 2022 Q2
Q1 2022 23,012,119 +4,800,000 +26% 31 Mar 2022 10-Q/A 25 Nov 2022 2022 Q1
Q4 2021 23,012,119 +4,802,667 +26% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 23,012,119 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 22,812,119 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 18,212,119 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 18,209,452 +5,765,287 +46% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 12,444,165 31 Dec 2019 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.